These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12468919)

  • 1. Acute myelogenous leukemia and glycogen storage disease 1b.
    Pinsk M; Burzynski J; Yhap M; Fraser RB; Cummings B; Ste-Marie M
    J Pediatr Hematol Oncol; 2002 Dec; 24(9):756-8. PubMed ID: 12468919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged granulocyte colony stimulating factor use in glycogen storage disease type 1b associated with acute myeloid leukemia and with shortened telomere length.
    Li AM; Thyagu S; Maze D; Schreiber R; Sirrs S; Stockler-Ipsiroglu S; Sutherland H; Vercauteren S; Schultz KR
    Pediatr Hematol Oncol; 2018 Feb; 35(1):45-51. PubMed ID: 29652549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte colony-stimulating factor in glycogen storage disease type 1b. Results of the European Study on Glycogen Storage Disease Type 1.
    Visser G; Rake JP; Labrune P; Leonard JV; Moses S; Ullrich K; Wendel U; Groenier KH; Smit GP
    Eur J Pediatr; 2002 Oct; 161 Suppl 1():S83-7. PubMed ID: 12373578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the diagnosis, treatment, and follow-up of a group of Turkish pediatric glycogen storage disease type 1b patients with varying clinical presentations and a novel mutation.
    Küçükçongar Yavaş A; Engin Erdal A; Bilginer Gürbüz B; Ünlüsoy Aksu A; Kasapkara ÇS
    J Pediatr Endocrinol Metab; 2023 Nov; 36(11):1092-1099. PubMed ID: 37791580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen storage disease.
    Kannourakis G
    Semin Hematol; 2002 Apr; 39(2):103-6. PubMed ID: 11957192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b.
    Calderwood S; Kilpatrick L; Douglas SD; Freedman M; Smith-Whitley K; Rolland M; Kurtzberg J
    Blood; 2001 Jan; 97(2):376-82. PubMed ID: 11154211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory bowel disease-like colitis in glycogen storage disease type 1b.
    Yamaguchi T; Ihara K; Matsumoto T; Tsutsumi Y; Nomura A; Ohga S; Hara T
    Inflamm Bowel Dis; 2001 May; 7(2):128-32. PubMed ID: 11383585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
    McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
    Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empagliflozin for treating neutropenia and neutrophil dysfunction in 21 infants with glycogen storage disease 1b.
    Grünert SC; Gautschi M; Baker J; Boyer M; Burlina A; Casswall T; Corpeleijn W; Çıki K; Cotter M; Crushell E; Derks TGJ; Haas D; Kilavuz S; Kingma SDK; Korman SH; Kozek A; de Laet C; Mundy H; Nassogne MC; Quintero V; Rossi A; Spenger J; Spiegel R; Stephenne X; Stojkov D; Tal G; Veiga-da Cunha M; Wortmann SB
    Mol Genet Metab; 2024 Jun; 142(2):108486. PubMed ID: 38733639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogen storage disease type Ib: the first case in Taiwan.
    Hsiao HJ; Chang HH; Hwu WL; Lam CW; Lee NC; Chien YH
    Pediatr Neonatol; 2009 Jun; 50(3):125-8. PubMed ID: 19579760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymptomatic critical hypoglycaemia: a dangerous presentation of glycogen storage disease type Ib in infancy.
    Bock DE; Rupar CA; Prasad C
    Acta Paediatr; 2011 Sep; 100(9):e130-2. PubMed ID: 21352356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor.
    Dale DC; Bolyard AA; Marrero T; Kelley ML; Makaryan V; Tran E; Leung J; Boxer LA; Kishnani PS; Austin S; Wanner C; Ferrecchia IA; Khalaf D; Maze D; Kurtzberg J; Zeidler C; Welte K; Weinstein DA
    Curr Opin Hematol; 2019 Jan; 26(1):16-21. PubMed ID: 30451720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of neutrophil membrane function underlies granulocyte-colony stimulating factor action in glycogen storage disease 1b.
    Lesma E; Riva E; Giovannini M; Di Giulio AM; Gorio A
    Int J Immunopathol Pharmacol; 2005; 18(2):297-307. PubMed ID: 15888252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute myelogenous leukemia and malignant hyperthermia in a patient with type 1b glycogen storage disease.
    Simmons PS; Smithson WA; Gronert GA; Haymond MW
    J Pediatr; 1984 Sep; 105(3):428-31. PubMed ID: 6590826
    [No Abstract]   [Full Text] [Related]  

  • 15. Glycogen storage disease type 1b: an early onset severe phenotype associated with a novel mutation (IVS4) in the glucose 6-phosphate translocase (SLC37A4) gene in a Turkish patient.
    Oguz MM; Aykan E; Yilmaz G; Aytekin C; Karaer K; Açoğlu EA
    Genet Couns; 2014; 25(4):389-94. PubMed ID: 25804016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusual oral manifestations and evolution in glycogen storage disease type Ib.
    Mortellaro C; Garagiola U; Carbone V; Cerutti F; Marci V; Bonda PL
    J Craniofac Surg; 2005 Jan; 16(1):45-52. PubMed ID: 15699644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycogen storage disease type Ib: infectious complications and measures for prevention.
    Wendel U; Schroten H; Burdach S; Wahn V
    Eur J Pediatr; 1993; 152 Suppl 1():S49-51. PubMed ID: 7686491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LONG TERM MANAGEMENT OF GLYCOGEN STORAGE DISEASE TYPE 1B: A BRAZILIAN TERTIARY CENTER EXPERIENCE.
    Takao MMV; Sandy NS; Riccetto AGL; Tommaso AMA
    Arq Gastroenterol; 2021; 58(1):87-92. PubMed ID: 33909803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus guidelines for management of glycogen storage disease type 1b - European Study on Glycogen Storage Disease Type 1.
    Visser G; Rake JP; Labrune P; Leonard JV; Moses S; Ullrich K; Wendel U; Smit GP;
    Eur J Pediatr; 2002 Oct; 161 Suppl 1():S120-3. PubMed ID: 12373585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte colony-stimulating factor corrects the neutropenia associated with glycogen storage disease type Ib.
    Wang WC; Crist WM; Ihle JN; Arnold BA; Keating JP
    Leukemia; 1991 Apr; 5(4):347-9. PubMed ID: 1709246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.